• head_banner_01

Factory source N Acetyl Carnitine Benefits - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our company has been concentrating on brand strategy. Customers' pleasure is our greatest advertising. We also source OEM service for N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine, Acetyl Tributyl Citrate 77-90-7, Diphenylacetonitrile, Accurate process devices, Advanced Injection Molding Equipment, Equipment assembly line, labs and software advancement are our distinguishing feature.
Factory source N Acetyl Carnitine Benefits - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:

Product Detail

NO.

Products

CAS No.

 Application

Key Quality Indicator

Purity

Isomer

SI *

Max *

Moisture

1

Fmoc-Lys(Mtt)-OH 167393-62-6 Lysine side chain modification

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤1.0%

2

Fmoc-Lys(Alloc)-OH 146982-27-6 Lysine side chain modification

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

3

Fmoc-Lys(ivDde)-OH 150629-67-7 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

Fmoc-Lys(Mmt)-OH 159857-60-0 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

5

Fmoc-Glu-OtBu 84793-07-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

6

Glu-OtBu 45120-30-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

7

Octadecanedioic acid 871-70-5 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

8

Octadecanedioic acid   mono-tert-butyl ester 843666-40-0 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

9

tBu-OOC-C16-CO-Glu-OtBu 1188328-39-3 SemaglutideFragment A

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

10

AEEA 134978-97-5 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

11

AEEA-OH.HCl 134979-01-4 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

12

Fmoc-AEEA-OH 166108-71-0 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

13

Boc-AEEA-OH 108466-89-3 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

14

AEEA-AEEA 1143516-05-5 Semaglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

15

Fmoc-AEEA-AEEA-OH 560088-89-3 SemaglutideFragment B

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

16

Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH 1118767-16-0 SemaglutideFragment C

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

17

tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu 1118767-15-9 SemaglutideFragment D

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

18

Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH 1662688-20-1 Semaglutide Fragment E

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

19

Boc-His(Trt)-OH 32926-43-5 The end is histidine

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤4.0%

20

Fmoc-Aib-OH 94744-50-0 Semaglutide

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

21

Boc-His(Trt)-Aib-OH 2061897-68-3 Semaglutide

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤2.0%

22

Fmoc-Glu(OtBu)-Gly-OH 866044-63-5 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

23

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH 1169630-31-2? Semaglutide Fragment F

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

24

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS 1169630-40-3 Semaglutide Fragment G

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

25

Fmoc-Arg(pbf)-Gly-OH 660846-80-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

26

Fmoc-Ala-Ala-OH 87512-31-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

27

Fmoc-Thr(tBu)-Phe-OH 1260609-75-3 ? GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

28

Palmitic acid 1957/10/3 Liraglutide Fragment 1

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

29

Palm-Glu-OtBu NA Liraglutide Fragment 2

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

30

Palm-Glu(NES)-OtBu NA Liraglutide Fragment 3

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

31

Fmoc-Lys(Palm-Glu-OtBu)-OH 1491158-62-3 Liraglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

32

Hexadecanedioic acid 505-54-4 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

33

Hexadecanedioic acid   mono-tert-butyl ester 843666-27-3 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

34

tBu-OOC-C14-CO-Glu-OtBu NA Insulin degludec Fragment I

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

35

tBu-OOC-C14-CO-Glu(NES)-OtBu NA Insulin degludec Fragment II

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

SI *= Specific Impurity

Max*= Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

Sanitization

Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.


Product detail pictures:

Factory source N Acetyl Carnitine Benefits - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex detail pictures


Related Product Guide:

With our excellent administration, potent technical capability and strict top quality control technique, we go on to provide our consumers with trusted quality, reasonable price ranges and fantastic providers. We intention at becoming one among your most trusted partners and earning your fulfillment for Factory source N Acetyl Carnitine Benefits - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Turin, British, Canberra, We adopted technique and quality system management, based on "customer orientated, reputation first, mutual benefit, develop with joint efforts", welcome friends to communicate and cooperate from all over the world.
  • The factory technical staff gave us a lot of good advice in the cooperation process, this is very good, we are very grateful.
    5 Stars By Alberta from Chicago - 2017.09.09 10:18
    This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
    5 Stars By Anna from Hungary - 2018.12.11 11:26
    Write your message here and send it to us